Cancer Marijuana Research Studies

Before purchasing marijuana from a Florida medical marijuana treatment center (MMTC) – or dispensary – patients must first qualify for a medical marijuana certification; CannaMD provides qualified patients with the state-required recommendation to complete this process.

According to Florida state law, patients suffering from cancer may qualify for medical marijuana treatment.

Patients can see if they qualify for free by completing a brief form or calling 1 (855) 420-9170.

For additional information on cancer, please see CannaMD‘s Cancer Patient Resource Page.

CannaMD welcomes the opportunity to connect with fellow physicians and facilitate medical cannabis care.

For additional information, including how to refer cancer patients and request complementary referral cards, please visit CannaMD‘s Physician Resource Page.

While the list below is not exhaustive, we hope you will enjoy the following primary source articles reviewing cancer and marijuana research:

• Antineoplastic activity of cannabinoids
• Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use
• Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy
• Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism
• Cannabinoids: Potential anticancer agents
• Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
• Delta-9 tetrahydrocannabinol inhibits growth and metastasis of lung cancer
• Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor 
• Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
• NTP toxicology and carcinogenesis studies of 1-trans-delta(9)-tetrahydrocannabinol in F344 rats and B6C3F1 mice
• Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
• The current state and future perspectives of cannabinoids in cancer biology